Fingerprint
Dive into the research topics of 'Phase II study of topotecan and bevacizumab in advanced, refractory non-small-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II study of topotecan and bevacizumab in advanced, refractory non-small-cell lung cancer
Steven F. Powell, Amer Beitinjaneh, Mathewos Tessema, Robin L. Bliss, Robert A. Kratzke, Joseph Leach, Arkadiusz Z. Dudek
Research output: Contribution to journal › Article › peer-review
16
Scopus
citations